RESMED, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 191.4 USD | -0.08% |
|
-7.00% | +11.28% |
| 25/06 | Oppenheimer Downgrades ResMed to Market Perform From Outperform | MT |
| 24/06 | Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
ResMed, Inc. specializes in designing, manufacturing and marketing respiratory disorders diagnosis, treatments and management (primarily sleep respiratory disorders). Net sales break down by family of products as follows:
- medical devices (50.4%);
- masks (37.9%);
- software as a service (11.7%).
At the end of June 2021, the group had 6 production sites located in the United States (2), Australia, China, Singapore and Malaysia.
The United States accounts for 61.4% of net sales.
Calendar
01/08/2024
- Q4 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
191.4
USD
Average target price
220.4
USD
Spread / Average Target
+15.15%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +11.28% | 2.81TCr | |
| +4.18% | 21TCr | |
| +8.00% | 19TCr | |
| +31.86% | 16TCr | |
| +33.21% | 11TCr | |
| +2.28% | 6.61TCr | |
| +21.14% | 5.62TCr | |
| +0.11% | 4.9TCr | |
| -6.76% | 3.82TCr | |
| +0.78% | 3.6TCr |
- Stock Market
- Equities
- RMD Stock
- News ResMed, Inc.
- Insider Sell: Resmed
